相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis
Yan-Yang Tao et al.
EXPERT REVIEW OF VACCINES (2021)
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial
Yanxia Wang et al.
VACCINE (2021)
Dose effect of influenza vaccine on protection against laboratory-confirmed influenza illness among children aged 6 months to 8 years of age in southern China, 2013/14-2015/16 seasons: a matched case-control study
Chuanxi Fu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China
Yuemei Hu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
Yuemei Hu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres
Stephanie Pepin et al.
VACCINE (2019)
Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability
Jan Hendriks et al.
VACCINE (2018)
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
Zhaojun Mo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase Ill randomized controlled study
Stephanie Pepin et al.
Human Vaccines & Immunotherapeutics (2016)
Comparing vaccines: A systematic review of the use of the non-inferiority margin in vaccine trials
R. Donken et al.
VACCINE (2015)
Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015)
Luzhao Feng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age
David P. Greenberg et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children
Varsha K. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
Stephanie Pepin et al.
VACCINE (2013)
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
David P. Greenberg et al.
VACCINE (2013)
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
Carrie Reed et al.
VACCINE (2012)
The rationale for quadrivalent influenza vaccines
Christopher S. Ambrose et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
Jacqueline M. Katz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010
Lars R. Haaheim et al.
Influenza and Other Respiratory Viruses (2011)
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
Laurent Coudeville et al.
BMC MEDICAL RESEARCH METHODOLOGY (2010)
Dual Seasonal Patterns for Influenza, China
Yue-Long Shu et al.
EMERGING INFECTIOUS DISEASES (2010)
分享论文
